Navigation Links
Campbell Alliance Clinical Development Practice to Conduct Two Workshops at 44th DIA Annual Meeting
Date:6/17/2008

ice President in the Clinical Development practice. He specializes in helping clients improve their clinical development operations and business processes to optimize the flow of critical information, increase the efficacy of key processes, and enhance organizational capabilities. Mr. Dietlin earned his MBA from DePaul University's Kellstadt Graduate School of Business and has a BA from Loyola University of Chicago.

On the day after Mr. Dietlin's workshop, Tuesday, June 24, Mr. Tyson will conduct a workshop titled "Becoming a Sponsor of Choice for Clinical Investigators" from 8:00 am to 9:30 am. The workshop, which is part of the Clinical Trial Management/Clinical Supplies track, will discuss key factors driving investigators' choices of clinical study sponsors. It will also explore tactics for identifying a pharmaceutical or biotech company's strengths and weaknesses with respect to conducting clinical trials, as well as examine strategies for improving a company's relationship with the study sites and investigators it values most.

"It's critical that a pharmaceutical company do everything it can to be the study sponsor that sites prefer to work with -- the sponsor of choice -- because there are so many clinical trials that are competing for the same patients," Mr. Tyson said. "Companies will gain a clear advantage if they understand what's behind an investigator's or study site's decision to work with a particular sponsor," he said.

As the head of Campbell Alliance's Clinical Development Practice, Mr. Tyson leads a team that provides a range of operational improvement services to clinical development organizations within pharmaceutical and biotech companies, as well as at leading contract research organizations (CROs). He is a veteran of numerous electronic-data-capture-related initiatives, and brings a wealth of knowledge and experience in process improvement, organizational design, and clinical development to his consulting engagements.


'/>"/>
SOURCE Campbell Alliance
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Campbell Alliance to Moderate Senior-Level Panel Discussion at Windhover Pharmaceutical Strategic Alliances Conference
2. Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference
3. Campbell Alliance Named Best Place to Work by Triangle Business Journal
4. Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver
5. Campbell Alliance Launches New Practice Area Focused on Trade and Distribution
6. Campbell Alliance Trade and Distribution Practice to Chair CBI 3rd Annual Fee for Service and EDI Data Management Conference
7. Campbell Alliance Brand Management Practice to Discuss Managing Launch Logistics at the EyeForPharma Oncology Summit
8. Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBIs Early Commercialization Conference
9. Campbell Alliance Sales Practice to Conduct Workshop at EyeForPharma SFE Europe Conference
10. Campbell Alliance Managed Markets Practice to Take a Leadership Role at the CBI Forum on Effective Product Pricing and Modeling Strategies
11. Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 10, 2014 Product and ... very low abundance and are often “lost in ... time-consuming. , Join presenters Dr. Rowel Tobias, Senior ... John Anders, Head of Quality at Nanotherapeutics, Inc., ... that can speed detection and quantitation while achieving ...
(Date:7/10/2014)... Robert Harman, DVM, Founder and CEO of Vet-Stem, ... announce the relaunch of his highly informative blog, now named ... “ What are Stem Cells ?” Dr. Harman’s purpose ... in the basics of stem cell therapy so that pet ... of treatment when considering regenerative medicine. , A veterinarian by ...
(Date:7/10/2014)... 10, 2014 On July 9 ... , presented Russia,s first national ... The Company is developing a unique project called ... develops a number of innovative drugs based on monoclonal ... ceremony took place at the International Exhibition "Innoprom 2014" ...
(Date:7/10/2014)... D.C., April 15, 2014 -- According to the ... to nuclear security comes from terrorists acquiring sufficient ... to construct a crude nuclear explosive device. The ... nuclear trafficking have involved gram-level quantities, which can ... , According to a new study appearing this ...
Breaking Biology Technology:Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2Sensitive detection method may help impede illicit nuclear trafficking 2
... St. Joseph,s Hospital and Medical Center and the University ... agreement to create the Valley Fever Center based at the ... who has more than 30 years of experience in treating ... of Excellence in Tucson in 1996. The center ...
... At the Heart Failure Society of America,s 15th Annual ... System, announced that B-type natriuretic peptide (BNP) may have ... signs of decompensation in advance of acute presentations.   ... and sponsored by Alere Inc., is the first of ...
... Biotherapeutics (OTC.BB: NWBO) (NORTHWEST BIO) today announced that ... Cancer Immunotherapy: A Long-Awaited Reality Conference on Thursday, ... Medicine in New York City.  The single-day conference ... stakeholders to engage in discussions, exchange information, and ...
Cached Biology Technology:St. Joseph's Hospital, University of Arizona Create Valley Fever Center in Phoenix 2HABIT Study Highlights Home BNP Testing May Allow for Earlier Interventions and Better Management of Heart Failure Patient 2HABIT Study Highlights Home BNP Testing May Allow for Earlier Interventions and Better Management of Heart Failure Patient 3NORTHWEST BIO Will Present at the Second Annual "Cancer Immunotherapy: A Long Awaited Reality Conference" at the New York Academy of Medicine, October 6, 2011 2NORTHWEST BIO Will Present at the Second Annual "Cancer Immunotherapy: A Long Awaited Reality Conference" at the New York Academy of Medicine, October 6, 2011 3NORTHWEST BIO Will Present at the Second Annual "Cancer Immunotherapy: A Long Awaited Reality Conference" at the New York Academy of Medicine, October 6, 2011 4
(Date:7/11/2014)... The increased risk of kidney injury related to the ... the mass of HES molecules, according to a report ... the International Anesthesia Research Society (IARS). , The "total ... HES on cultured human renal proximal tubule cells (PTCs), ... colleagues of University Hospital Wrzburg, Austria. Other factorssuch ...
(Date:7/11/2014)... Research and Markets has announced the addition ... Analysis Size Share Growth Trends and Forecast to 2019" ... http://photos.prnewswire.com/prnh/20130307/600769 The rising number of ... high level security in both private and public sector. ... and passwords, tokens etc. are vulnerable to attacks. Biometrics ...
(Date:7/10/2014)... , June 27, 2014  Pomerantz LLP has ... Inc. ("Provectus" or the "Company")(NYSE-MKT: PVCT) and certain ... United States District Court, Middle District of ... behalf of a class consisting of all persons ... securities between December 17, 2013 and May 22, ...
Breaking Biology News(10 mins):In lab studies, hydroxyethyl starch has direct harmful effects on kidney cells 2International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3
... Scientists found that in 14 independent studies, the yields ... other biofuel feedstocks, such as corn, soybean, sorghum, and ... not yet been evaluated exist. According to bioenergy ... a low risk of unintended land use change. Biomass ...
... have developed a novel system for delivery of growth ... diabetic foot ulcers. In their work published in ... of Sciences , the team from the MGH Center ... keratinocyte growth factor (KGF), a protein known to play ...
... year,s Deepwater Horizon oil spill, nearly 800,000 gallons of chemical ... coming out of the wellhead nearly one mile deep in ... assess how well the strategy worked at breaking up oil ... and her colleagues report that a major component of the ...
Cached Biology News:Growth-factor-containing nanoparticles accelerate healing of chronic wounds 2First study of dispersants in Gulf spill suggests a prolonged deepwater fate 2First study of dispersants in Gulf spill suggests a prolonged deepwater fate 3First study of dispersants in Gulf spill suggests a prolonged deepwater fate 4
... an 18 amino acid synthetic peptide whose sequence corresponds to residues ... is (amino to carboxy terminus): M(1) - A - S - ... - S - P - R - D - A - ... may be used for neutralization and control experiments with the polyclonal ...
... Bisulfite Kit enables complete conversion of ... than 6 hours. The highly sensitive ... DNA degradation and a spin-column-based purification ... and reliable results for all downstream ...
... from high throughput synthesis are new and unique ... These products provide a large number (from hundreds ... in a microtube as a mixture or in ... sequence. This is a custom product so RNA ...
... is a fixative useful for routine procedures. ... is stable and will decalcify small bone ... can be stained successfully with most stains, ... stabilizes red blood cell membranes and cosinophil ...
Biology Products: